National Institute of Allergy and Infectious Diseases-Tickborne Diseases

Active

Assistance listing
93.8TD
Agency
Grant awards
Not on record

Program facts

Treasury account
  • 75-0885-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated .

About this program

The National Institute of Allergy and Infectious Diseases (NIAID) funds research to improve understanding, prevention, diagnosis, and treatment of tickborne diseases under Assistance Listing 93.8TD, with no current open grant opportunity posted as of October 2026.

The program supports a narrow scope: basic and translational research on tickborne pathogens and transmission mechanisms, diagnostic development targeting accuracy, sensitivity, and speed of detection, and therapeutic development for persistent or severe tickborne infections. NIAID structures awards as research project grants with peer review conducted first by a Scientific Review Group at the Center for Scientific Review, followed by an NIAID advisory council that assesses scientific merit, programmatic relevance, and fiscal feasibility. NIAID program staff and delegated HHS officials make final funding decisions based on scientific and technical merit, program priorities including set-asides, budget availability for the fiscal year, study impact and importance, experimental design quality, investigator capability, and resource sufficiency. Renewals compete with new applications and require an active or recently active NIH research project grant and continuity of the Principal Investigator unless a justifiable change is documented.

The source provides no grant award portfolio data (award count, dollar totals, funding concentration among agencies, or recent award dates), no representative recent grant awards with recipients or amounts, and no recent opportunities with due dates or eligibility constraints beyond the renewal requirement. The program description does not indicate whether awards have been disbursed recently, the frequency of solicitations, or typical award magnitudes. Applicants submit via grants.gov following guidance in a Notice of Funding Opportunity (NOFO); the source does not specify when the most recent NOFO was posted or when the next solicitation cycle will open. The legally binding Notice of Award, issued by the NIAID Grants Management Officer, specifies the approved budget period within the project period and obligates federal funds; this document is the authoritative record of award terms and conditions.

Objective and description

Objective

Improve understanding of tickborne pathogens and transmission. Advance diagnostics to develop more accurate, sensitive, and early diagnostic tests. Develop better treatment with improved therapeutics and treatment strategies for persistent or severe

Description

Support and conduct research to improve the understanding, prevention, diagnosis, and treatment of tickborne diseases to reduce their impact on public health.

How to apply

Criteria for selecting proposals

The following will be considered in making funding decisions: scientific and technical merit of the proposed project as determined by scientific peer review, availability of funds, relevance of the proposed project to program priorities. Assessing the importance/impact of the proposed study and its goals. Evaluating the quality of the experimental design and approach. The ability of the proposed investigator or research group to successfully execute the project. Examine whether the proposed resources, infrastructure, and institutional facilities are sufficient to support the project. Budgetary considerations are reviewed to determine the necessity of the components requested. This entails examining whether the proposed expenditures align well with the activities and scale of the project. Determining whether all items requested are essential for successful execution.

Award procedure

Applicants submit the grant application in grants.gov following guidance provided in the Notice of Funding Opportunity (NOFO). Center for Scientific Review (CSR) then assigns the application. A peer review process by Scientific Review Group (SRG) determines an overall impact score or percentile. A second level peer review is done by NIAID's advisory council which determines if there is concurrence with the initial peer review, program relevance, and fiscal considerations. NIAID selects proposals based on several factors including scientific and technical merit, programmatic priorities/set-asides, and budget availability that fiscal year. The Council makes recommendations to NIAID leadership. After advisory council review NIAID program staff evaluates applications. NIAID officials under delegated HHS authority consider all factors and make funding decisions. The NIAID Grants Management Officer (GMO) issues a Notice of Award (NOA) and only the GMO has authority to obligate federal funds. The NOA is the legally binding document which obligates federal funds. The NOA specifies the approved budget period which is the specific time interval within the project period for which funds are provided.

Renewals

Renewals compete with new applications in peer review. You must have an active or recently active NIH research project grant. The same Principal Investigator must remain in place unless there is a justifiable reason for a new PI. Renewal applications use the SF 424 format.

Quick answers

What is Assistance Listing 93.8TD?

Assistance Listing 93.8TD is National Institute of Allergy and Infectious Diseases-Tickborne Diseases, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for National Institute of Allergy and Infectious Diseases-Tickborne Diseases?

Its CFDA number is 93.8TD: Assistance Listing numbers were called CFDA numbers before 2018.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program